TFS Articles

Search by keyword, or choose a Focus Topic to view all articles within that area of study.

  • Clear Filters

Found 191 Results
Page 4 of 22
Article

2025 Clinical Trial Trends: AI, FSP, and Patient-Centric CRO Predictions

Key market predictions & trends for clinical trials in 2025 include FSP, AI, wearable tech, rare disease research, and targeted therapies.

Read Now
Article

Evolution of Clinical Trials in Europe: End of an Era

Explore key regulatory changes from the CTD to the CTR, benefits & challenges, and its long-term impact on clinical trials in Europe.

Read Now
Article

What to look for in an Oncology CRO: A Guide for Sponsors in 2025

Select the right Oncology CRO in 2025 using insights on innovative solutions & patient-focused trials to advance clinical development.

Read Now
Article

2025 Clinical Research Trends to Love

Discover heartwarming advances in clinical research for 2025, from AI-driven breakthroughs to advancements in personalized medicine.

Read Now
Article

World Cancer Day 2025: Reflecting on Research Milestones and Future Promises

Explore the latest advancements in cancer research on World Cancer Day 2025, from AI-powered breakthroughs to innovative immunotherapies.

Read Now
Article

Celebrating Community Impact: TFS’s 2024 Philanthropy and Sustainability in Clinical Research

Discover TFS HealthScience’s 2024 philanthropic efforts, contributing over €10,000 to health-related charities and organizations.

Read Now
Article

Advancing Gene Therapy for Rare Diseases: Charting the Path to Transformative Treatments

Learn about the unique challenges in clinical trials, regulatory hurdles, and the role of collaboration in gene therapy for rare diseases.

Read Now
Article

Precision Medicine: A New Era for Neurological Breakthroughs

Explore how precision medicine is revolutionizing neurological care. Learn about advancements, challenges, and the role of CROs in 2025.

Read Now
Article

Top Contract Research Organizations (CROs) for Oncology in 2025

Learn how these top CROs are advancing cancer research with innovative trial designs, specialized expertise, and cutting-edge technology.

Read Now